Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
United States Gasoline Fund Lp
UGA
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
US Stock MarketDetailed Quotes
Dermata Therapeutics (DRMA)
- 1.350
- +0.090+7.14%
Close Apr 16 15:59 ET
- 1.365
- +0.015+1.13%
Pre 06:59 ET
5.43MMarket Cap-0.17P/E (TTM)
1.370High1.260Low222.46KVolume1.300Open1.260Prev Close300.48KTurnover7.59%Turnover RatioLossP/E (Static)4.02MShares9.89952wk High0.87P/B3.96MFloat Cap1.10052wk Low--Dividend TTM2.93MShs Float16680.000Historical High--Div Yield TTM8.72%Range %1.100Historical Low1.351Avg Price1Lot Size
Dermata Therapeutics (DRMA) Key Financial Indicators
DRMA Earnings per Share (EPS)
According to the latest financial report of Dermata Therapeutics, the latest earnings per share (TTM) for the company is -1.52. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
DRMA Free Cash Flow (FCF)
Interested in knowing about Dermata Therapeutics's free cash flow? The latest report shows it as -1.33M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
DRMA Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Dermata Therapeutics shows that the company's current ratio is 4.79, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
DRMA Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Dermata Therapeutics, the quick ratio is 4.59, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
DRMA Return on Equity (ROE)
Want to learn more about the financial health of Dermata Therapeutics? The latest ROE figure is -36.57%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
DRMA Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Dermata Therapeutics, the total asset return on investment (ROA) is -28.79%.
Currency: USD
Quarterly
Loading...
DRMA Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Dermata Therapeutics's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
DRMA Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Dermata Therapeutics, the net profit margin is --, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! On the 16th, US President Trump stated that the next round of talks between the US and
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm